Mon.Aug 17, 2020

article thumbnail

5 Ways That Digital Signage Improves a Doctor’s Office

Pharma Mirror

When you many patients think of a doctor’s office, hospital, or healthcare facility, they picture a stuffy, cold, and outdated facility that increases your anxiety. Offices with old decor prevent patients from visiting the doctor regularly and feeling relaxed. But what if there was a way to modernize the office affordably to make it more. The post 5 Ways That Digital Signage Improves a Doctor’s Office appeared first on Pharma Mirror Magazine.

Doctors 246
article thumbnail

Aiming for immunotherapy boost, Bristol Myers deepens ties with Dragonfly

Bio Pharma Dive

For $475 million in near-term cash, Bristol Myers will get access to an immunotherapy based on technology that's drawn interest from rival Merck.

200
200
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Women in Bio: OMass Taps Biogen Vet Nathalie Franchimont for Board of Directors

BioSpace

“Joining the board will allow me to help guide and influence the development of a product from bench to bedside,” Franchimont told BioSpace. “I look forward to contributing to ongoing discussions on translation from bench science to the clinic, and ultimately to making real differences in the liv.

article thumbnail

Sanofi, seeking control of key drug, to buy Principia for $3.7B

Bio Pharma Dive

The acquisition significantly increases Sanofi's bet on Principia's chief asset, an experimental drug for multiple sclerosis now in late-stage testing.

Drugs 161
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

FDA Halts Poseida’s CAR-T Trial for Prostate Cancer Following Patient Death

BioSpace

Shares of Poseida Therapeutics plunged more than 20% in premarket trading this morning after the company announced the U.S. Food and Drug Administration halted a cancer drug trial due to safety concerns.

Trials 131
article thumbnail

Roche wins FDA approval for 1st self-administered biologic for rare eye disease

Bio Pharma Dive

Enspryng is the second drug OK'd in three months for an autoimmune disorder that causes blindness and impaired mobility, but it's the only one that patients can take at home.

More Trending

article thumbnail

Sanofi adds BTK inhibitors to pipeline with $3.68bn Principia Biopharma acquisition

pharmaphorum

Sanofi is to buy Principia Biopharma for up to $3.68 billion, adding a potential multiple sclerosis drug to its pipeline. The French pharma said it will pay $100 per share in cash for San Francisco-based Principia, which specialises in Bruton’s kinase (BTK) inhibitor drugs, after the deal was unanimously agreed by both boards of directors. Sanofi’s acquisition builds on a partnership to develop central nervous system drugs that began in late 2017.

Trials 123
article thumbnail

Researchers Continue to Face Several Hurdles in COVID-19 Clinical Trials

BioSpace

Despite the urgent need for more research into the coronavirus, the New York Times reported on August 14 that there have been numerous testing delays, staffing shortages and space constraints tying up the process.

article thumbnail

Gates Foundation gives Dynavax COVID-19 grant to scale up adjuvant production

BioPharma Reporter

Dynavax gets Bill & Melinda Gates Foundation funding to scale up production of adjuvant for use in COVID-19 vaccines.

article thumbnail

Study Shows Interferon Levels Could Be Biomarkers for COVID-19 Cytokine Storm

BioSpace

Shortly before COVID-19 patients’ conditions advance from moderate to severe, their levels of type I interferon (IFN) are present in the bloodstream drop.

120
120
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Meeting Surrogate Endpoint Wins NS Pharma Approval for DMD Drug Viltepso

XTalks

Duchenne muscular dystrophy (DMD) patients with a mutation in exon 53 of the dystrophin gene now have a second approved treatment option, and Xtalks spoke with Sharon Hesterlee, PhD, Muscular Dystrophy Association executive vice president and chief research officer, to learn more. Viltepso (viltolarsen), an injectable drug developed by NS Pharma, has gone through the US Food and Drug Administration’s (FDA) accelerated approval process, but the company has yet to confirm that the drug has a true

Drugs 105
article thumbnail

Merck to Build $1.3 Billion Research Hub in London

BioSpace

The new research hub will be called the London Discovery Research Centre and is expected to open by 2025.

Research 145
article thumbnail

UK strikes deals with J&J, Novavax to source 90m COVID-19 vaccines

BioPharma Reporter

UK government reaches agreements to buy millions of COVID-19 vaccines from Johnson & Johnson and Novavax, bringing total stockpile up to 340 million.

article thumbnail

Eli Lilly Strikes $1 Billion Deal with Innovent for Checkpoint Inhibitor

BioSpace

Eli Lilly will aim a checkpoint inhibitor it co-developed for the Chinese market at the United States and other western markets.

Marketing 120
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

‘Cyborg’ technology could enable new diagnostics, merger of humans and AI

Scienmag

Credit: David Martin WASHINGTON, Aug. 17, 2020 — Although true “cyborgs” — part human, part robotic beings — are science fiction, researchers are taking steps toward integrating electronics with the body. Such devices could monitor for tumor development or stand in for damaged tissues. But connecting electronics directly to human tissues in the body is […].

article thumbnail

Transforming Your Informed Consent Process

Cloudbyz

If you’ve been around the clinical research industry, the concept of obtaining electronic consent is probably familiar to you. Considering the current pandemic we are in, many sponsors, sites, and CROs are slowly turning towards an eConsent process. Here are some of the hot features that most organizations are currently looking for in their eConsent solution: User Friendly.

article thumbnail

Machine learning reveals role of culture in shaping meanings of words

Scienmag

Credit: Thompson et al. What do we mean by the word beautiful? It depends not only on whom you ask, but in what language you ask them. According to a machine learning analysis of dozens of languages conducted at Princeton University, the meaning of words does not necessarily refer to an intrinsic, essential constant. Instead, […].

article thumbnail

Company Spotlight: Cue Biopharma Innovates in the Immunotherapy Space with its Immuno-STAT Platform

XTalks

Immunotherapy continues to be a burgeoning field, with immune-based therapies being among the leading treatments being developed in oncology and autoimmunity. To learn more about innovations in the field, Xtalks spoke to Anish Suri, PhD, president and chief scientific officer of Cue Biopharma about the company’s initiatives in the development of immune-based biological compounds for the treatment of cancers and autoimmune diseases.

Protein 98
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Antibiotics associated with increased risk of inflammatory bowel disease

Scienmag

Credit: Gustav Mårtensson Antibiotics use, particularly antibiotics with greater spectrum of microbial coverage, may be associated with an increased risk of new-onset inflammatory bowel disease (IBD) and its subtypes ulcerative colitis and Crohn’s disease. That is according to a study by researchers at Karolinska Institutet in Sweden and Harvard Medical School in the United States, […].

article thumbnail

Inside Operation Warp Speed

NY Times

The goal of the initiative is admirable: getting a coronavirus vaccine out to Americans and saving lives as soon as possible. It is not, however, without its problems.

article thumbnail

Energy-efficient tuning of spintronic neurons

Scienmag

Credit: Johan Åkerman and Shunsuke Fukami The human brain efficiently executes highly sophisticated tasks, such as image and speech recognition, with an exceptionally lower energy budget than today’s computers can. The development of energy-efficient and tunable artificial neurons capable of emulating brain-inspired processes has, therefore, been a major research goal for decades.

article thumbnail

Novateur study points toward potential COVID-19 treatment

Outsourcing Pharma

Researchers at Novateur Ventures have released a strategy that examines leukotrienes as the cause for hyperinflammatory response in severe cases.

Research 105
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Novartis Wins Patent Battle for its Blockbuster MS Drug Gilenya

BioSpace

The legal ruling, subject to appeal, protects the Swiss pharma giant’s revenue stream from the blockbuster drug for a little bit longer.

Drugs 104
article thumbnail

New research will improve early warning of devastating megastorms

Scienmag

Study finds land surface conditions can affect mesoscale convective systems while they are on the move Credit: Françoise GUICHARD / Laurent KERGOAT / CNRS Photo Library Ground-breaking scientific research will make it easier to predict the path of some of the world’s most powerful storms, enabling communities to better protect themselves from severe flooding.

article thumbnail

What can pharma marketing learn from other regulated industries?

pharmaphorum

The financial world, like the pharmaceutical industry, must operate within a tightly-defined regulatory environment, and in doing so has proved adept at connecting with its customers. N o one industry is ever quite like another, but there are some valuable lessons for pharma marketing from examining how the financial sector uses technology, builds brands on social channels and approaches digital content.

article thumbnail

No limit yet for carbon nanotube fibers

Scienmag

Rice lab makes case for high-performance carbon nanotube fibers for industry Credit: Pasquali Research Group/Rice University HOUSTON – (Aug. 17, 2020) – Carbon nanotube fibers made at Rice University are now stronger than Kevlar and are inching up on the conductivity of copper. The Rice lab of chemical and biomolecular engineer Matteo Pasquali reported in […].

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Sanofi buys Principia Biopharma

Pharma Times

The move bolsters the French drug giant's core R&D areas of autoimmune and allergic diseases

Drugs 106
article thumbnail

2D materials for ultrascaled field-effect transistors

Scienmag

One hundred candidates under the ab initio microscope Credit: Mathieu Luisier/ETH Zurich With the increasing miniaturization of electronic components, researchers are struggling with undesirable side effects: In the case of nanometer-scale transistors made of conventional materials such as silicon, quantum effects occur that impair their functionality.

article thumbnail

How To Improve CRA Quality of Life in Clinical Research

Clinical Trial Gurus

Some companies are aware of the effects that CRA turnover has on a company’s bottom line. Because of this some companies take a unique approach with their relationships with CRAs and make it a point to identify monitors who may be overworked. Any additional accommodations that can be made for employees may actually improve work performance and employee quality of life.

article thumbnail

Penguins are Aussies. Or are they Kiwis?

Scienmag

First genome comparison gives insight into penguin origins, evolution Credit: Photo courtesy of Juliana Vianna From the four-foot-tall emperor penguin to the aptly named foot-long little penguin, these unique flightless birds have invaded habitats from Antarctica to the equator, not to mention the hearts of the public. A comparison of the full genomes of 18 […].

Genome 85
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.